Comment on “Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial”
Journal of the American Academy of Dermatology · 2026-11
DOI: 10.1016/j.jaad.2026.07.151 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-11. Verfasst von Fang Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Dalian Medical University, Dalian, China; College of Laboratory Medicine, Dalian Medical University, Dalian, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of Dalian Medical University, Dalian, China; College of Laboratory Medicine, Dalian Medical University, Dalian, China.
- The First Affiliated Hospital of Dalian Medical University, Dalian, China.
- The First Affiliated Hospital of Dalian Medical University, Dalian, China. Electronic address: 2471244772@qq.com.
Zitieren
APA
Jiang, F., Wang, Y., Guo, B., & Zhao, D. (2026). Comment on “Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial”. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.07.151
Vancouver
Jiang F, Wang Y, Guo B, Zhao D. Comment on “Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial”. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.07.151
BibTeX
@article{Jiang2026,
author = {Jiang, Fang and Wang, Yixuan and Guo, Bingli and Zhao, Dan},
title = {Comment on “Ivarmacitinib is associated with rapid clinical improvement and immune remodeling in palmoplantar pustulosis: A multi-center, single-arm clinical trial”},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.07.151}
}
EUVIMED